New perspectives in type 2 Gaucher disease.
Sidransky
E
E
Clinical Neuroscience Branch, National Institute of Mental Health, Bethesda, Maryland, USA.
D000818:Animals; D004195:Disease Models, Animal; D005776:Gaucher Disease / Q000150:complications / Q000201:enzymology / Q000235:genetics / Q000473:pathology / Q000628:therapy; D005962:Glucosylceramidase / Q000235:genetics / Q000378:metabolism / Q000627:therapeutic use; D006801:Humans; D007057:Ichthyosis / Q000209:etiology; D007223:Infant; D007231:Infant, Newborn; D051379:Mice; D018345:Mice, Knockout / Q000502:physiology
D005962:Glucosylceramidase